VisCardia Selected in Top 50 Medical Device Start-Ups by MedTech Innovator to Participate in a Global Flagship Showcase and Accelerator Program prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
VisCardia Announces Issuance of American Medical Association CPT® Category III Codes for Synchronized Diaphragmatic Stimulation (SDS®)
News provided by
Share this article
Share this article
PORTLAND, Ore., March 16, 2021 /PRNewswire/ VisCardia Inc., a privately held medical device developer, announced today that the American Medical Association (AMA) has issued (ten) 10 new Current Procedural Terminology (CPT
®) Category III codes in support of the implant procedure and management of Synchronized Diaphragmatic Stimulation (SDS
®) therapy as provided through VisCardia s proprietary, implantable VisONE
® heart failure management system.
The CPT Category III codes for SDS will be effective Jan. 1, 2022, and provide the ability to track the VisONE implant and related procedures moving forward, including during VisCardia s anticipated US IDE study.